In 1975, Thomas Fitzpatrick developed a numerical classification for different skin types as a way to estimate the response of different types of skin to ultraviolet (UV) ray exposure. To this day the Fitzpatrick Scale remains a recognised dermatological tool for determining human skin pigmentation; the likely impact of UV overexposure on an individual and their risk of skin cancer related issues.
Type 1 - someone who always experiences sunburn.
Type 2 - someone who almost always experiences sunburn.
Type 3 - someone who experiences mild sunburn from time to time.
Type 4 - someone who only experiences minimal sunburn.
Type 5 - someone who rarely experiences sunburn.
Type 6 - someone who never experiences sunburn.
A Type 1 skin person is likely to have red or blonde hair, blue eyes, freckles and pale skin which only burns with sun exposure, never tans.
A person who has Type 1 skin is most at risk of skin cancer through UV exposure. Dermatologists and skin doctors recommend to individuals with Type 1 skin to self assess their skin on an ongoing basis, that they attend at least annual skin checks and proactively manage their skin health by using UPF50+ sun protective clothing and sunscreen.
Dermatologists recommend UPF50+ sun protective clothing as the best form of skin cancer prevention. Solbari offers an award-winning range of UPF50+ sun protective clothing, sun-hats, sun protective arm sleeves, umbrellas and other accessories.
Solbari, Australian Sun Protection offers a range of award-winning UPF50+ sun protective clothing, umbrellas, arm sleeves, sun hats and other accessories which are aimed at skin cancer prevention and helping individuals protect their skin when outdoors.
The SOLBARI Team
This blog post is for information purpose only.
We understand that getting an appointment with a dermatologist or skin doctor can be challenging and expensive.
We decided it would be great to bring the best early skin cancer detection technology direct to the Solbari global community.
Skin Cancer rates increase 150% in UK
Cancer Research UK announced this week that skin cancer incidence rates in the UK have increased markedly.
The introduction of “lockdowns”, the restriction of movement and non-essential healthcare activities being suspended have had an impact on the diagnosis of cancer cases including skin cancer.
Countries around the World are now evaluating the unintended consequences of Covid-19 restrictions on the diagnosis of cancer. Sadly, cancer related death rates are expected to increase over the coming years due to the delay in diagnosis.